0001209191-20-038874.txt : 20200625
0001209191-20-038874.hdr.sgml : 20200625
20200625160014
ACCESSION NUMBER: 0001209191-20-038874
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200624
FILED AS OF DATE: 20200625
DATE AS OF CHANGE: 20200625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arkowitz David
CENTRAL INDEX KEY: 0001296999
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37718
FILM NUMBER: 20989264
MAIL ADDRESS:
STREET 1: C/O FLEXION THERAPEUTICS, INC.
STREET 2: 10 MALL ROAD, SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001566373
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522386345
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
BUSINESS PHONE: 508-473-5993 X119
MAIL ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-24
0
0001566373
Spring Bank Pharmaceuticals, Inc.
SBPH
0001296999
Arkowitz David
C/O SPRING BANK PHARMACEUTICALS, INC.
35 PARKWOOD DRIVE
HOPKINTON
MA
01748
1
0
0
0
Stock Option (right to buy)
1.60
2020-06-24
4
A
0
7500
0.00
A
2030-06-23
Common Stock
7500
7500
D
Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 24, 2020, the date of the Issuer's 2020 Annual Meeting of Stockholder, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date.
/s/ Lori Firmani, attorney-in-fact
2020-06-25